课题基金 / 基金详情

Microbial Correlates of Bacterial Vaginosis Treatment Failure and Recurrence in H

Microbial Correlates of Bacterial Vaginosis Treatment Failure and Recurrence in H
细菌性阴道病治疗失败和复发的微生物相关性
批准号:
8067129
负责人:
MICHAEL J FERRIS
金额:
$46.9万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-01 至 2013-04-30

项目摘要

项目成果

MICHAEL J FERRIS的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):本研究的长期目标是实现阴道细菌种类及其对健康和疾病的影响的更合理、更现实的范例。相关性:细菌性阴道病(BV)是与阴道刺激相关的妇科就诊的最常见原因。更重要的是,这种非常常见的疾病与严重的后遗症有关,包括早产和艾滋病毒感染的风险增加。BV是一个微生物之谜。这似乎是细菌种类的变化,而不是由特定病原体引起的真正的组织感染,但原因不明。甲硝唑的标准治疗经常失败,复发率很高。目前推荐的治疗相对无效的事实可以解释为什么旨在预防BV并发症的抗生素治疗试验失败。虽然来自处女研究的证据表明BV可能是内源性的,但对性活跃女性的研究强烈表明它是性传播的。治疗后的复发感染率很高,尽管伴侣治疗似乎不能降低这些感染率,但数据强烈表明,男性在将BV相关微生物重新引入阴道中发挥作用。见解:最近对阴道植物群进行的不依赖于培养的PCR分析表明,阴道微环境比以前理解的要复杂得多。分子工具现在可以开始更好地了解BV的病因,它如何导致人类疾病,为什么目前的治疗是如此不足。假设:BV治疗失败与迄今为止未研究的、唯一可定义的细菌物种聚生体相关,而复发与与男性伴侣的性接触相关,男性伴侣携带这些先前未知的BV相关物种。具体目标:(1)将使用一组20个物种特异性定量真实的时间PCR测定,以获得临床定义BV的女性及其男性伴侣中细菌物种组成和相对丰度的详细概况。(2)将对接受口服甲硝唑治疗BV的一夫一妻制女性及其未经治疗的男性伴侣进行随访,以确定微生物种类组成、治疗失败和复发性BV之间的相关性。这些分析将控制可能影响结局以及治疗依从性的行为因素。重要性:这些结果将导致更有效的诊断和治疗BV的方法,并预防与这种常见综合征相关的严重后遗症。公共卫生相关性:细菌性阴道病(BV)是与阴道刺激相关的妇科就诊的最常见原因。更重要的是,这种非常常见的疾病与严重的后遗症有关,包括早产和艾滋病毒感染的风险增加。本研究的结果将提高我们对健康和疾病中阴道细菌植物群的认识,并导致更有效的诊断和治疗细菌性阴道病的方法,以及预防与这种常见综合征相关的严重后遗症。
英文摘要
DESCRIPTION (provided by applicant): The long term objective of this research is to achieve a more rational, realistic paradigm of vaginal bacterial species and their influence on health and disease. Relevance: Bacterial Vaginosis (BV) is the most frequent cause of gynecological visits relating to vaginal irritation. More significantly, this very common ailment is associated with severe sequelae including preterm delivery and increased risk of HIV infection. BV is a microbiologic enigma. It appears to be a change in bacterial species that colonize the vaginal epithelium rather than a true tissue infection by a specific pathogen, however the cause is unknown. Standard treatment with metronidazole often fails, and recurrence rates are high. The fact that currently recommended therapy is relatively ineffective may explain why antibiotic treatment trials directed at preventing the complications of BV have failed. While evidence from studies of virgins suggests BV can arise endogenously, studies of sexually active women strongly suggest it is sexually transmitted. Recurrent infection rates following treatment are high and though partner treatment appears not to reduce these rates, the data strongly suggest that the male plays a role in re introducing BV associated organisms into the vagina. Insight: Recent cultivation-independent PCR analyses of vaginal flora have shown that the vaginal micro environment is much more complex than previously understood. Molecular tools are now available begin to better understand the etiology of BV, how it causes human disease and why current treatment is so inadequate. Hypothesis: BV treatment failures are associated with here-to-fore unstudied, uniquely definable, bacterial species consortia while recurrence is related to sexual contact with male partners who harbor these previously unknown BV-associated species. Specific Aims: (1) A panel of twenty species-specific quantitative real time PCR assays will be used to obtain detailed profiles of bacterial species-composition, and relative abundance, in women with clinically defined BV and in their male partners. (2) A cohort of monogamous women receiving oral metronidazole for treatment of BV, and their untreated male partners, will be followed to determine correlations between microbial species composition, treatment failure and recurrent BV. These analyses will be controlled for behavioral factors that might influence outcomes as well as treatment compliance. Significance: The results should lead to more effective methods of diagnosing and treating BV, and preventing the serious sequelae associated with this common syndrome. PUBLIC HEALTH RELEVANCE: Bacterial Vaginosis (BV) is the most frequent cause of gynecological visits relating to vaginal irritation. More significantly, this very common ailment is associated with severe sequelae including preterm delivery and increased risk of HIV infection. The results of this study should improve our understanding of vaginal bacterial flora in health and disease, and lead to more effective methods of diagnosing and treating bacterial vaginosis and preventing the serious sequelae associated with this common syndrome.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Microbial Correlates of Bacterial Vaginosis Treatment Failure and Recurrence in H
  • 批准号:
    7800959
  • 项目类别:
  • 资助金额:
    $47.51万
  • 财政年份:
    2009
  • 负责人:
    MICHAEL J FERRIS
  • 依托单位:
Microbial Correlates of Bacterial Vaginosis Treatment Failure and Recurrence in H
  • 批准号:
    7654600
  • 项目类别:
  • 资助金额:
    $32.88万
  • 财政年份:
    2009
  • 负责人:
    MICHAEL J FERRIS
  • 依托单位:
Microbial Correlates of Bacterial Vaginosis Treatment Failure and Recurrence in H
  • 批准号:
    8261674
  • 项目类别:
  • 资助金额:
    $46.91万
  • 财政年份:
    2009
  • 负责人:
    MICHAEL J FERRIS
  • 依托单位:
Microbial Correlates of Bacterial Vaginosis Treatment Failure and Recurrence in H
  • 批准号:
    7687874
  • 项目类别:
  • 资助金额:
    $39.15万
  • 财政年份:
    2008
  • 负责人:
    MICHAEL J FERRIS
  • 依托单位:
海外基金